 |
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
- Therapeutics-Clinical (Late) - - - ,
- - -
Accentia Biopharmaceuticals - Tampa,
FL ; Tampa, FL - acquisition of late stage pharmaceuticals and improvement through new delivery technologies
Acologix - Hayward,
CA - biology-based drug discovery and development
Acusphere - Watertown,
MA - drug delivery using porus microparticles
Adolor - Exton,
PA - pain relief therapeutics
Advanced Life Sciences - Woodridge,
IL - infectious disease, oncology and respiratory diseases
Adventrx Pharmaceuticals - San Diego,
CA - pharmaceutical research through licensing agreements
Alfacell - Bloomfield,
NJ - RNase therapeutics
Amarin - London,
UK; Mill Valley, CA ; Sweden - therapeutics for neurology and pain management
Anesiva - South San Francisco,
CA - pain management pharmaceuticals
AnorMED - Vancouver,
British Columbia UK - small molecule therapeutics
Aphios - Woburn,
MA - infectious disease and cancer therapeutics
Argenta Discovery - Harlow,
Essex UK - drug discovery
AtheroGenics - Alpheretta,
GA - development small molecule therapeutics for chronic inflammatory diseases
Avant Immunotherapeutics - Needham,
MA - develops immunotherapeutics
Axonyx - New York,
NY - acquisition and development of memory-related therapeutics
Basilea Pharmaceutica - Basel,
Switzerland - drug-resistant therapeutics
BCY LifeSciences - Toronto,
Ontario Canada - late stage pharmaceutical development company
BioNumerik - San Antonio,
TX - cancer therapeutics
BioSante Pharmaceuticals - Lincolnshire,
IL - hormone therapeutics
BioSpecifics Technologies - Lynbrook,
NY - wound healing and tissue remodeling therapeutics
Biothera - Eagan,
MN - complex carbohydrate biopolymers therapeutics and products
Biotie Therapies - Turku,
Finland - CNS and inflammatory therapeutics
CancerVax Corp. - Carlsbad,
CA ; Marina Del Ray, CA - therapeutic cancer vaccines and angiogenesis-controlling antibodies
Cellegy Pharmaceuticals - South San Francisco,
CA - therapeutics targeting gastroenterology conditions and sexual dysfunction using topical formulations and nitric oxide donor technologies
CeNeS Pharmaceuticals - Cambridge,
UK - drug development in the areas of pain, anaesthesia and neurology.
Chrysalis BioTechnology - Galveston,
TX - tissue repair therapeutics
Clinical Data - Newton,
MA - pharmaceutical company with many late stage candidates
Corcept Therapeutics - Menlo Park,
CA - cortisol regulating therapeutics
Corgentech - South San Francisco,
CA - therapeutics based on transcription factor decoys
Cubist Pharmaceuticals - Lexington,
MA ; Slough, Berkshire, UK - antimicrobial drug development
Cumberland Pharmaceuticals - Nashville,
TN - acquires late-stage development and marketed pharmaceuticals
Curacyte - Munich,
Germany; Chapel Hill, NC. - biopharmaceutical company
CyDex Pharmaceuticals - Lenexa,
KS - drug formulation/delivery technology
Cypress Bioscience - San Diego,
CA - therapeutics for fibromyalgia syndrome
Debiopharm - Lausanne,
Switzerland - development of in-licensed therapeutics
Delcath Systems - New York,
NY - specialty pharmaceuticals and medical devices
Dendreon - Seattle,
WA - monoclonal antibody therapeutics for cancer treatments
Discovery Labs - Doylestown,
PA - respiratory therapeutics
DOR BioPharma - Ewing,
NJ - oral and mucosal drug delivery
Dragon Pharmaceuticals - Vancouver,
B.C. Canada - genetically engineered human proteins for therapeutic use
Dynavax - Berkeley,
CA - development of therapeutics based on "immunostimulatory sequences"
DynPort Vaccine - Frederick,
MD - vaccine therapeutics for biodefense purposes
Encysive Pharmaceuticals - Houston,
TX - small molecule drug development for cardiovascular and inflammatory dieseases
Enhance Biotech - New York,
NY - therapeutics aimed at the lifestyle market (in-licenses products at the clinical trial stage)
ESP Pharma - Edison,
NJ - acquisition and development of commercially available therapeutics and late-stage development specialty drugs
Favrille - San Diego,
CA - develops patient-specific immunotherapeutics for lymphoma and diseases of the immune system
Genelabs Technologies - Redwood City,
CA - SLE (Lupus) therapeutics
Genitope - Fremont,
CA - cancer immunotherapeutics
Genmab - Copenhagen,
Denmark - human antibody therapeutics
H3 Pharma - Montreal,
Quebec Canada - development of in-licensed therapeutics through clinical trials
Halozyme Therapeutics - San Diego,
CA - recombinant human enzyme therapeutics
IDM Pharma - Irvine,
CA - immunotherapeutics for the treatment of cancer
ImClone Systems - New York,
NY - monoclonal antibody cancer therapeutics
Inex Pharmaceuticals - Burnaby,
British Columbia Canada - cancer therapeutics and drug delivery systems
InSite Vision - Alameda,
CA - ophthalmic diagnositcs and drug delivery
Inspire Pharmaceuticals - Durham,
NC - therapeutics for the trestment of mucosal deficiency diseases
IntraBiotics Pharmaceuticals - Mountain View,
CA - antimicrobial and oncology therapeutics
Introgen Therapeutics - Austin,
TX ; Houston, TX - gene-based therapeutics
Ironwood Pharmaceuticals - Cambridge,
MA - drug discovery and development
Ista Pharmaceuticals - Irvine,
CA - Hyaluronidase-based therapeutics for eye diseases
Jerini - Berlin,
Germany - peptide-based drugs
Maxim Pharmaceuticals - San Diego,
CA - histamine-related drug therapies
MGI Pharma - Bloomington,
MN - oncology therapeutic development and manufacturing
NeoRx - Seattle,
WA - targeted delivery of cancer therapeutics
Neurocrine Biosciences - San Diego,
CA - discovery and development of neurological disease therapeutics
NeuroSearch - Ballerup,
Denmark - CNS therapeutics
Newron Pharmaceuticals - Bresso (Milan),
Italy - CNS and pain pharmaceuticals
NitroMed - Charlotte,
NC - nitric oxide-based therapeutics
NPS Pharmaceuticals - Bedminster,
NJ - small molecule and recombinant protein therapeutics
OncoGenex Technologies - Vancouver,
British Columbia Canada - cancer therapeutics
Oncothyreon - Seattle,
WA ; Edmonton, Alberta, Canada ; Tucson, AZ - immunotherapy and cancer therapeutics (cancer vaccines)
Onyx Pharmaceuticals - Emeryville,
CA - human disease therapuetics
Opko - Miami,
FL - eye disease therapeutics
Orexigen Therapeutics - La Jolla,
CA - obesity therapeutics
Oscient Pharmaceuticals - Waltham,
MA - genomics-based pharmaceuticals and genomic services
Ovation Pharmaceuticals - Deerfield,
IL - acquisition of branded and late stage clinical therapeutics
Pain Therapeutics - South San Francisco,
CA - painkiller development
Peninsula Pharmaceuticals - Alameda,
CA - anti-infective therapeutics
Pharmacyclics - Sunnyvale,
CA Sunnyvale, CA - small molecule (texaphyrins)-based pharmaceuticals
Pharmaxis - Sydney,
Australia - therapeutics for the treatment of chronic respiratory and autoimmune diseases
Pharmos - Iselin,
NJ ; Rehovot, Israel - CNS therapeutics
Pozen - Chapel Hill,
NC - migraine therapeutics, focusing on drug development
Regeneron Pharmaceuticals - Tarrytown,
NY ; Rensselaer, NY - therapeutics for treatment of obesity, rheumatoid arthritis, and cancer
Renovo - Manchester,
UK - scar prevention therapeutics
Repros Therapeutics - The Woodlands,
TX - develops pharmaceutical products related to the reproductive system
Santarus - San Diego,
CA - gastrointestinal disease therapeutics
Sciele Pharma - Atlanta,
GA - development of therapeutics for Cardiovascular, Diabetes, Women's Health and Pediatrics diseases.
Sinclair Pharmaceuticals - Godalming,
Surrey UK - late stage pharmaceutical development and marketing
Sosei - Tokyo,
Japan - therapeutics development primarily through in-licensing
Spectrum Pharmaceuticals - Irvine,
CA - in-licensing, clinical development and commercialization of oncology drugs
SuperGen - Dublin,
CA - oncology therapeutics (generally acquired in late stage development)
Tercica - South San Francisco,
CA - endocrine therapeutics
Theravance - South San Francisco,
CA - multivalent drug design
Tolerx - Cambridge,
MA - immune system therapeutics
Trimeris - Durham,
NC - HIV therapeutic development
Unigene Laboratories - Fairfield,
NJ - oral and nasal delivery of large-market peptide drugs
Vasogen - Mississauga,
Ontario Canada - immune modulation therapies for the treatment of cardiovascular disease
Verus Pharmaceuticals - San Diego,
CA - pediatric therapeutics
Vical - San Diego,
CA - "naked DNA" gene delivery for disease treatment
Vicuron Pharmaceuticals - Fremont,
CA - antibiotic and antifungal therapeutics
Vion Pharmaceuticals - New Haven,
CT - cancer therapeutics
ViRexx Medical - Edmonton,
Alberta Canada - cancer therapeutics
Vivus - Mountain View,
CA - therapeutics for obesity, diabetes, sleep anpnea and sexual disfunction
Wilex - Munich,
Germany - small molecule and antibody cancer therapeutics
YM BioSciences - Mississauga,
Ontario Canada - clinical development of cancer therapeutics
|
|
